Epigral Ltd posted a 27% year-on-year revenue increase to Rs 745.99 crore for Q2 FY2027. While annual profit improved, the company faced a sequential decline in net profit, falling from Rs 99.75 crore in Q1 to Rs 65.08 crore this quarter. Strategic moves include a new subsidiary, Epigral Advanced Materials, and ongoing capital deployment into wind-solar hybrid power projects.
Epigral Ltd Reports Q2 FY2027 Financial Results
Consolidated Revenue: Rs 745.99 Crore | Consolidated Profit After Tax: Rs 65.08 Crore
Reader Takeaway: Strong year-on-year revenue growth is tempered by sequential profit compression; keep an eye on power project execution.
What just happened
Epigral Ltd has released its unaudited financial results for the quarter ending September 30, 2026. The company recorded a consolidated revenue of Rs 745.99 crore, a notable increase from the Rs 587.36 crore reported in the same quarter last year. Consolidated Profit After Tax (PAT) stood at Rs 65.08 crore, compared to Rs 51.10 crore in Q2 FY2026.
Why this matters
While the company demonstrates healthy top-line expansion on a year-on-year basis, the sequential dip in profitability is a key area of interest. PAT fell from Rs 99.75 crore in the preceding June 2026 quarter to Rs 65.08 crore, reflecting potential margin pressure that investors should monitor closely in the coming periods.
Corporate and Strategic Developments
Epigral is actively diversifying and securing its operational energy needs. The company incorporated a new wholly-owned subsidiary, 'Epigral Advanced Materials Limited', in July 2026. Additionally, the company is doubling down on its energy strategy by investing a further Rs 5.31 crore in Non-cumulative Optionally Convertible Debentures of its power producer partners to facilitate the sourcing of wind-solar hybrid energy.
Risks to watch
The primary concern remains the sequential decline in profitability and the dependency on the successful execution of power project agreements. Any fluctuation in input costs or delays in the operational efficiency of the newly incorporated subsidiary could impact future performance metrics.
What to track next
Watch for management commentary regarding the sequential profit decline to understand if it stems from seasonal volatility or rising operational costs. Further updates on the progress of the 'Epigral Advanced Materials Limited' subsidiary will also be essential for assessing future growth drivers.